Novo Nordisk Hits A 10-Year Low - I Think The Market Is Making A Mistake (NYSE:NVO)

Novo Nordisk A/S ( NVO ) shocked the market once again with a major drop on the news that its semaglutide didn’t prove to slow the progression of Alzheimer's disease:I write about stocks I’m personally interested in adding to my portfolio. I’m not a professional advisor, but I study business and economics and analyze markets full-time. My writing is meant for both complete beginners — I avoid unnecessary complexity — and advanced readers, as I always aim to offer a distinct and well-reasoned perspective.I a ...